Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients

Journal of Bone and Mineral Metabolism

Volumn 26, Issue 1, 2008, Pages 66-72

  Doumouchtsis, Konstantinos K ^a   Kostakis, Alkis I ^a   Doumouchtsis, Stergios K ^a   Tziamalis, Marios P ^b   Stathakis, Charalambos P ^c   Diamanti Kandarakis, Evanthia ^a   Dimitroulis, Dimitrios ^a   Perrea, Despoina N ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b General Hospital of Kastoria   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Bone mineral density; Hemodialysis; Osteoprotegerin; Renal osteodystrophy; Total alkaline phosphatase

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; BONE DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FEMUR; FEMUR NECK; HEMODIALYSIS; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERUM; SKELETON; TRABECULAR BONE;

ADULT; AGED; ALKALINE PHOSPHATASE; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; FEMUR NECK; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PARATHYROID HORMONE; RANK LIGAND; RENAL DIALYSIS;

EID: 37349026168     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-007-0785-5     Document Type: Article

References (33)

1. Fu GK, Lin D, Zhang MY, Bikle DD, Shackleton CH, et al (1997) Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 11:1961-1970
2. 3 in chronic renal failure. Kidney Int 33:1049-1058
3. Massry SG, Coburn JW, Lee DB, Jowsey J, Kleeman CR (1973) Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects. Ann Intern Med 78:357-364
4. Llach F, Massry SG, Singer FR, Kurokawa K, Kaye JH, Coburn JW (1975) Skeletal resistance to endogenous parathyroid hormone in patients with early renal failure. A possible cause for secondary hyperparathyroidism. J Clin Endocrinol Metab 41:339-345
5. Bover J, Jara A, Trinidad P, Rodriguez M, Felsenfeld AJ (1999) Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus. Bone (NY) 25:279-285
6. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, et al (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160-1166
7. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, et al (1993) The spectrum of bone disease in end-stage renal failure: an evolving disorder. Kidney Int 43:436-442
8. Coen G, Ballanti P, Balducci A, Calabria S, Fischer MS, et al (2002) Serum osteoprotegerin and renal osteodystrophy. Nephrol Dial Transplant 17:233-238
9. Horwood NJ, Elliott J, Martin TJ, Gillespie MT (1998) Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:4743-4746
10. Fletcher S, Jones RG, Rayner HC, Harnden P, Hordon LD, et al (1997) Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Nephron 75:412-419
11. Gerakis A, Hadjidakis D, Kokkinakis E, Apostolou T, Raptis S, Billis A (2000) Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol 13:437-443
12. Hampson G, Vaja S, Evans C, Chesters CA, Pettit R, et al (2002) Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephron 91:94-102
13. Urena P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, et al (2003) Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 18:2325-2331
14. Johnson DW, McIntyre HD, Brown A, Freeman J, Rigby RJ (1996) The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 16:34-40
15. Moe SM, Yu BO, Sprague SM (1993) Maintenance of bone mass in patients receiving dialytic therapy. Am J Kidney Dis 22:300-307
16. Gabay C, Ruedin P, Slosman D, Bonjour JP, Leski M, Rizzoli R (1993) Bone mineral density in patients with end-stage renal failure. Am J Nephrol 13:115-123
17. Stehman-Breen CO, Sherrard DJ, Alem AM, Gillen DL, Heckbert SR, et al (2000) Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58:2200-2205
18. Kaji H, Suzuki M, Yano S, Sugimoto T, Chihara K, et al (2002) Risk factors for hip fracture in hemodialysis patients. Am J Nephrol 22:325-331
19. Stejskal D, Zurek M, Bartek J, Jedelsky L, Ruzicka V (2001) Osteoprotegerin and bone density. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 145:75-76
20. Oh KW, Rhee EJ, Lee WY, Kim SW, Baek KH, et al (2005) Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males. Clin Endocrinol (Oxf) 62:92-98
21. Fukagawa M, Kazama JJ, Kurokawa K (2002) Renal osteodystrophy and secondary hyperparathyroidism. Nephrol Dial Transplant 17(suppl 10):2-5
22. Crisafulli A, Romeo A, Floccari F, Aloisi E, Atteritano M, et al (2005) Osteoprotegerin and bone mineral density in hemodiafiltration patients. Renal Fail 27:531-539
23. Nakashima A, Yorioka N, Doi S, Takasugi N, Shigemoto K, Kohno N (2006) Osteoprotegerin and bone mineral density in hemodialysis patients. Osteoporos Int 17:841-846
24. Seeman E, Wahner HW, Offord KP, Kumar R, Johnson WJ, Riggs BL (1982) Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest 69:1302-1309
25. Urena P, De Vernejoul MC (1999) Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 55:2141-2156
26. Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, et al (2005) Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Life Sci 77:1130-1139
27. Barnas U, Schmidt A, Seidl G, Kaider A, Pietschmann P, Mayer G (2001) A comparison of quantitative computed tomography and dual X-ray absorptiometry for evaluation of bone mineral density in patients on chronic hemodialysis. Am J Kidney Dis 37:1247-1252
28. Asaka M, Iida H, Entani C, Fujita M, Izumino K, et al (1992) Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis. Clin Nephrol 38:149-153
29. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, et al (1999) Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287-293
30. Bianchi ML, Colantonio G, Montesano A, Trevisan C, Ortolani S, et al (1992) Bone mass status in different degrees of chronic renal failure. Bone (NY) 13:225-228
31. Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K (1999) Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56:1084-1093
32. Kazama JJ (2004) Osteoprotegerin and bone mineral metabolism in renal failure. Curr Opin Nephrol Hypertens 13:411-415
33. Zayour D, Daouk M, Medawar W, Salamoun M, El-Hajj Fuleihan G (2004) Predictors of bone mineral density in patients on hemodialysis. Transplant Proc 36:1297-1301